Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts
Takaaki Sasaki(Asahikawa Medical College Hospital)
Cited by 15
Related Papers
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer
|Translational Lung Cancer Research|2021|11
Sotorasib resistance in KRAS G12C-mutant invasive mucinous adenocarcinoma with implications for VEGF-A
|npj Precision Oncology|2025|1